صفحه اصلی » همه » پیش بینی سهام » ARS Pharmaceuticals Inc. Common Stock پیش بینی

ARS Pharmaceuticals Inc. Common Stock پیش بینی: فردا, هفته, ماه, 5 سال

به روز شد: April 22 · 2026 at 07:03 UTC
▼ -4.16%Market Cap $778.49M · Technical analysis Bearish · Focus area Price + volatility

خلاصه پیش بینی

بازه زمانیقیمت پیش بینی شدهگذشتهتاریخیبینش
فردا$7.95 +1.41%دیروز$7.79 -0.59%Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.
Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.
هفته$8.18 +4.40%هفته گذشته$7.70 -1.85%The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.
The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.
ماه$8.57 +9.37%ماه گذشته$7.53 -3.94%The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
سال$9.16 +16.82%سال گذشته$7.29 -7.07%The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 سال$10.53 +34.29%5 سال پیش$6.71 -14.40%The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
فردا$7.95 +1.41%
دیروز$7.79 -0.59%
Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.
هفته$8.18 +4.40%
هفته گذشته$7.70 -1.85%
The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.
ماه$8.57 +9.37%
ماه گذشته$7.53 -3.94%
The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
سال$9.16 +16.82%
سال گذشته$7.29 -7.07%
The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 سال$10.53 +34.29%
5 سال پیش$6.71 -14.40%
The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

نمودار قیمت

تاریخیپیش بینیصعودینزولی
$8.34$8.14$7.94$7.73$7.531W AgoNow7D F

تحلیل فنی

فروشخنثیخرید کنید
Neutral
1
صعودی
3
خنثی
1
نزولی

شاخص های کلیدی

شاخصارزشسیگنال
Price$7.84 Mid
Daily Change-4.16% Below
Volatility Cap20.0% Mid
Confidence66% Above
Data Sourcenasdaq-screener Mid

داده های تاریخی

Current$7.84
Daily Change-4.16%
Market Cap$778.49M
Sourcenasdaq-screener
Current$7.84Daily Change-4.16%
Market Cap$778.49MSourcenasdaq-screener

سطوح پشتیبانی و مقاومت

$7.60Support 1
$7.84فعلی
$8.08Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

نقاط عطف قیمت

سطوح کلیدی و بافت تاریخی
Current$7.84Live reference price
Used as the anchor for generated forecast calculations.
Next Month$8.57Model projection+9.37%
Directional scenario based on capped drift.

دقت پیش بینی

مدل ما چگونه عمل کرده است
66%
جهت دار
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
الگوریتم ما هر هفته با استفاده از آخرین اقدام قیمت، رژیم نوسانات و سیگنال‌های نشانگر کالیبره می‌شود. دقت در بازه زمانی متفاوت است - حرکت کوتاه مدت قابل اعتمادتر از پیش بینی های بلند مدت است.
Short term
66%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

سناریوهای سرمایه گذاری

اگر امروز $1,000 را در SPRY سرمایه گذاری کنید
Bullish Scenario
$8.23
+5.00% from current
قیمت هدف$8.23
سناریوUpside momentum
احتمال58%
Base Scenario
$8.57
+9.37%
قیمت هدف$8.57
سناریوCapped drift
احتمال66%
Bearish Scenario
$7.45
-5.00% from current
قیمت هدف$7.45
سناریوVolatility drawdown
احتمال34%
اساس: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

عوامل پیش بینی

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 70/100
24H drift+1.41%
7D drift+4.40%
30D drift+9.37%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 67/100
1M outlook+9.37%
1Y outlook+16.82%
5Y outlook+34.29%

سوالات متداول

Q What is the ARS Pharmaceuticals Inc. Common Stock (SPRY) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), ARS Pharmaceuticals Inc. Common Stock is projected near $7.95 versus the current reference around $7.84. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for SPRY?
The weekly ARS Pharmaceuticals Inc. Common Stock model points to $8.18, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the ARS Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?
The ARS Pharmaceuticals Inc. Common Stock 1-month target is $8.57 (+9.37%), while the 1-year target is $9.16 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the ARS Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?
The ARS Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $10.53 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are SPRY support and resistance zones right now?
For ARS Pharmaceuticals Inc. Common Stock, nearest resistance is around $7.60, while nearest support is around $8.08. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the ARS Pharmaceuticals Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.